url_from,url_to
https://reatapharma.com/about-us/our-story/,http://reatapharma.wpengine.com/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/programs/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/patients/
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/investors-news/social-media-disclosure/,http://reatapharma.wpengine.com/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/about-us/our-story/,http://www.proxydocs.com/RETA
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/programs/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/careers/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/contact-us/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/
https://reatapharma.com/about-us/our-story/,https://clinicaltrials.gov/ct2/show/NCT03019185
https://reatapharma.com/programs/,http://reatapharma.wpengine.com/
https://reatapharma.com/careers/,http://reatapharma.wpengine.com/
https://reatapharma.com/programs/ctd-pah/,http://reatapharma.wpengine.com/
https://reatapharma.com/patients/,http://reatapharma.wpengine.com/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/patients/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/friedreichs-ataxia/,http://reatapharma.wpengine.com/
https://reatapharma.com/about-us/our-story/,https://clinicaltrials.gov/ct2/show/NCT02657356
https://reatapharma.com/about-us/our-story/,https://clinicaltrials.gov/ct2/show/NCT03366337
https://reatapharma.com/about-us/our-story/,https://clinicaltrials.gov/ct2/show/NCT02255435
https://reatapharma.com/about-us/our-story/,http://ow.ly/K7Jq30l4Pyv
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/sitemap/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/programs/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/investors-news/events-presentations/,http://reatapharma.wpengine.com/
https://reatapharma.com/careers/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/careers/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/patients/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/patients/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/patients/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/patients/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/investors-news/social-media-disclosure/,http://www.proxydocs.com/RETA
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/kidney-diseases/,http://reatapharma.wpengine.com/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/about-us/our-story/,https://twitter.com/reatapharma
https://reatapharma.com/about-us/our-story/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/about-us/our-story/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/our-science/in-licensing/,http://reatapharma.wpengine.com/
https://reatapharma.com/our-science/rta-1701/,http://reatapharma.wpengine.com/
https://reatapharma.com/programs/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/,https://reatapharma.com/programs/
https://reatapharma.com/programs/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/careers/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/careers/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/careers/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/careers/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/careers/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/careers/,https://reatapharma.com/programs/
https://reatapharma.com/careers/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/patients/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/patients/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/patients/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/patients/,https://reatapharma.com/programs/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/our-science/nrf2-activators/,http://reatapharma.wpengine.com/
https://reatapharma.com/about-us/board-of-directors/,http://reatapharma.wpengine.com/
https://reatapharma.com/about-us/leadership/,http://reatapharma.wpengine.com/
https://reatapharma.com/privacy-policy/,http://reatapharma.wpengine.com/
https://reatapharma.com/our-science/rta-901/,http://reatapharma.wpengine.com/
https://reatapharma.com/legal-message/,http://reatapharma.wpengine.com/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/programs/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/about-us/our-story/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/programs/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/careers/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/careers/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/careers/,https://reatapharma.com/patients/
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/
https://reatapharma.com/careers/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/programs/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/patients/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/patients/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/patients/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/patients/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/patients/,https://reatapharma.com/patients/
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/
https://reatapharma.com/patients/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/patients/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/patients/,http://www.proxydocs.com/RETA
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/careers/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/contact-us/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/
https://reatapharma.com/investors-news/social-media-disclosure/,https://twitter.com/reatapharma
https://reatapharma.com/investors-news/social-media-disclosure/,https://www.linkedin.com/company/reata-pharmaceuticals
https://reatapharma.com/investors-news/social-media-disclosure/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/investors-news/social-media-disclosure/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/sitemap/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/legal-message/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/programs/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/patients/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/programs/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/legal-message/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/legal-message/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/legal-message/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/legal-message/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/legal-message/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/legal-message/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/legal-message/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/legal-message/,https://reatapharma.com/programs/
https://reatapharma.com/legal-message/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/patients/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/sitemap/,http://reatapharma.wpengine.com/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/programs/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/programs/
https://reatapharma.com/programs/,https://reatapharma.com/patients/
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/
https://reatapharma.com/programs/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/patients/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/careers/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/careers/,http://www.proxydocs.com/RETA
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/programs/ctd-pah/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/patients/,https://reatapharma.com/careers/
https://reatapharma.com/patients/,https://reatapharma.com/contact-us/
https://reatapharma.com/investors-news/social-media-disclosure/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/,http://reatapharma.wpengine.com/
https://reatapharma.com/contact-us/,http://reatapharma.wpengine.com/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/programs/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/programs/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/programs/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/programs/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/patients/
https://reatapharma.com/legal-message/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/legal-message/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/legal-message/,https://reatapharma.com/patients/
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/sitemap/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/sitemap/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/sitemap/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/sitemap/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/sitemap/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/sitemap/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/patients/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/patients/
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/programs/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/careers/,https://reatapharma.com/careers/
https://reatapharma.com/careers/,https://reatapharma.com/contact-us/
https://reatapharma.com/careers/,https://reatapharma.com/
https://reatapharma.com/careers/,https://reatapharma.com/sitemap/
https://reatapharma.com/careers/,https://reatapharma.com/legal-message/
https://reatapharma.com/careers/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/careers/,https://twitter.com/reatapharma
https://reatapharma.com/careers/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/careers/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/contact-us/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/
https://reatapharma.com/programs/ctd-pah/,https://clinicaltrials.gov/ct2/show/NCT02657356
https://reatapharma.com/programs/ctd-pah/,http://ow.ly/K7Jq30l4Pyv
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/19837821
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/24355642
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/16218473
https://reatapharma.com/patients/,https://reatapharma.com/
https://reatapharma.com/patients/,https://cardinalclinicaltrial.com/
https://reatapharma.com/patients/,https://www.phoenixclinicaltrial.com/
https://reatapharma.com/patients/,https://www.moxiestudy.com/
https://reatapharma.com/patients/,https://www.catalysttrial.com/
https://reatapharma.com/patients/,https://reatapharma.com/patients/compassionate-use-policy/
https://reatapharma.com/patients/,https://reatapharma.wpengine.com/patients/compassionate-use-policy/
https://reatapharma.com/patients/,https://reatapharma.com/sitemap/
https://reatapharma.com/patients/,https://reatapharma.com/legal-message/
https://reatapharma.com/patients/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/kidney-diseases/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/,https://reatapharma.com/programs/
https://reatapharma.com/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/contact-us/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/contact-us/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/contact-us/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/contact-us/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/contact-us/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/contact-us/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/contact-us/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/patients/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/patients/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/patients/
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/privacy-policy/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/patients/
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/privacy-policy/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/our-science/rta-901/,http://www.proxydocs.com/RETA
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/
https://reatapharma.com/legal-message/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/legal-message/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/legal-message/,http://www.proxydocs.com/RETA
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/careers/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/contact-us/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/
https://reatapharma.com/programs/friedreichs-ataxia/,https://clinicaltrials.gov/ct2/show/NCT02255435
https://reatapharma.com/programs/friedreichs-ataxia/,http://ow.ly/K7Jq30l4Pyv
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/19347027
https://reatapharma.com/sitemap/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/sitemap/,https://reatapharma.com/patients/
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/
https://reatapharma.com/sitemap/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/our-science/in-licensing/,http://www.proxydocs.com/RETA
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/our-science/rta-1701/,http://www.proxydocs.com/RETA
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/,https://reatapharma.com/careers/
https://reatapharma.com/programs/,https://reatapharma.com/contact-us/
https://reatapharma.com/programs/,https://reatapharma.com/
https://reatapharma.com/programs/,https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/
https://reatapharma.com/programs/,https://reatapharma.com/programs/iga-nephropathybard/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/investors-news/events-presentations/,http://www.proxydocs.com/RETA
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/careers/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/careers/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/ctd-pah/,https://www.ncbi.nlm.nih.gov/pubmed/24709277
https://reatapharma.com/programs/ctd-pah/,https://www.ncbi.nlm.nih.gov/pubmed/26669915
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/23983198
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/16496078
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/22281797
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/19282344
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/26291092
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/20507945
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/21457778
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/19720606
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/23741300
https://reatapharma.com/patients/,https://twitter.com/reatapharma
https://reatapharma.com/patients/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/patients/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/patients/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/careers/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/contact-us/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/
https://reatapharma.com/programs/kidney-diseases/,http://alportsyndrome.org/what-is-alport-syndrome/
https://reatapharma.com/programs/kidney-diseases/,http://investors.reatapharma.com/phoenix.zhtml?ID=2342167&c=254306&p=irol-newsArticle
https://reatapharma.com/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/,https://reatapharma.com/patients/
https://reatapharma.com/,https://reatapharma.gcs-web.com/
https://reatapharma.com/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/contact-us/,https://reatapharma.com/programs/
https://reatapharma.com/contact-us/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/contact-us/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/contact-us/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/contact-us/,https://reatapharma.com/patients/
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/
https://reatapharma.com/contact-us/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/contact-us/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/our-science/nrf2-activators/,http://www.proxydocs.com/RETA
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/about-us/board-of-directors/,http://www.proxydocs.com/RETA
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/about-us/leadership/,http://www.proxydocs.com/RETA
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/privacy-policy/,http://www.proxydocs.com/RETA
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/privacy-policy/,https://reatapharma.com/careers/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/careers/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/contact-us/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/legal-message/,https://reatapharma.com/careers/
https://reatapharma.com/legal-message/,https://reatapharma.com/contact-us/
https://reatapharma.com/legal-message/,https://reatapharma.com/
https://reatapharma.com/legal-message/,https://reatapharma.com/privacy-policy
https://reatapharma.com/legal-message/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/23859338
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/23859346
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/9577387
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/20156111
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/21550666
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/10319894
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/10500204
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/23350650
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/23574943
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/19158945
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/23951401
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/sitemap/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/sitemap/,http://www.proxydocs.com/RETA
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/careers/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/contact-us/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/sitemap/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/legal-message/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/our-science/in-licensing/,https://twitter.com/reatapharma
https://reatapharma.com/our-science/in-licensing/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/careers/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/contact-us/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/
https://reatapharma.com/our-science/rta-1701/,https://www.ncbi.nlm.nih.gov/pubmed/19076351
https://reatapharma.com/programs/,https://reatapharma.com/programs/type-1-diabetic-ckdbard/
https://reatapharma.com/programs/,https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/
https://reatapharma.com/programs/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/,https://twitter.com/reatapharma
https://reatapharma.com/programs/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/programs/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/careers/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/contact-us/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/
https://reatapharma.com/investors-news/events-presentations/,http://ow.ly/xiSb30l32TC
https://reatapharma.com/investors-news/events-presentations/,https://clinicaltrials.gov/ct2/show/NCT02036970
https://reatapharma.com/investors-news/events-presentations/,https://clinicaltrials.gov/ct2/show/NCT02657356
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/sitemap/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/legal-message/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/25926128
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/18065492
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/17363558
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/ctd-pah/,https://twitter.com/reatapharma
https://reatapharma.com/programs/ctd-pah/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/ctd-pah/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/programs/kidney-diseases/,http://ow.ly/K7Jq30l4Pyv
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/23720336
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/24195589
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/28978980
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600401/
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/25047252
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/26612656
https://reatapharma.com/,http://www.proxydocs.com/RETA
https://reatapharma.com/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/contact-us/,http://www.proxydocs.com/RETA
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/careers/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/contact-us/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179323/
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/23311665
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/22966038
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/careers/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/contact-us/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/sitemap/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/legal-message/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/about-us/board-of-directors/,https://twitter.com/reatapharma
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/careers/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/contact-us/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/sitemap/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/legal-message/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/about-us/leadership/,https://twitter.com/reatapharma
https://reatapharma.com/about-us/leadership/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/about-us/leadership/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/contact-us/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/
https://reatapharma.com/privacy-policy/,https://reatapharma.wpengine.com/
https://reatapharma.com/privacy-policy/,https://www.consumer.ftc.gov/topics/protecting-kids-online
https://reatapharma.com/privacy-policy/,https://reatapharma.com/sitemap/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/legal-message/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/privacy-policy/,https://twitter.com/reatapharma
https://reatapharma.com/privacy-policy/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/privacy-policy/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/privacy-policy/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/our-science/rta-901/,http://www.ncbi.nlm.nih.gov/pubmed/20955164
https://reatapharma.com/our-science/rta-901/,http://www.ncbi.nlm.nih.gov/pubmed/17656567
https://reatapharma.com/our-science/rta-901/,http://www.ncbi.nlm.nih.gov/pubmed/10605935
https://reatapharma.com/our-science/rta-901/,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049350/
https://reatapharma.com/our-science/rta-901/,http://www.ncbi.nlm.nih.gov/pubmed/24263156
https://reatapharma.com/our-science/rta-901/,https://kuscholarworks.ku.edu/handle/1808/10216
https://reatapharma.com/our-science/rta-901/,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517131/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/sitemap/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/legal-message/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/our-science/rta-901/,https://twitter.com/reatapharma
https://reatapharma.com/legal-message/,https://reatapharma.com/legal-message/
https://reatapharma.com/legal-message/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/legal-message/,https://twitter.com/reatapharma
https://reatapharma.com/legal-message/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/legal-message/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/legal-message/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/friedreichs-ataxia/,https://twitter.com/reatapharma
https://reatapharma.com/programs/friedreichs-ataxia/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/friedreichs-ataxia/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/programs/friedreichs-ataxia/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/sitemap/,https://reatapharma.com/careers/
https://reatapharma.com/sitemap/,https://reatapharma.com/contact-us/
https://reatapharma.com/sitemap/,https://reatapharma.com/
https://reatapharma.com/sitemap/,https://reatapharma.com/about-us/
https://reatapharma.com/sitemap/,https://reatapharma.com/share-your-fa-story/
https://reatapharma.com/sitemap/,https://reatapharma.com/share-your-fa-story/submission-guidelines/
https://reatapharma.com/our-science/in-licensing/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/our-science/in-licensing/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/our-science/rta-1701/,https://www.ncbi.nlm.nih.gov/pubmed/26388774
https://reatapharma.com/our-science/rta-1701/,http://www.autoimmuneregistry.org/autoimmune-statistics/
https://reatapharma.com/our-science/rta-1701/,https://www.ncbi.nlm.nih.gov/pubmed/21081189
https://reatapharma.com/our-science/rta-1701/,http://www.jimmunol.org/content/200/1_Supplement/121.14
https://reatapharma.com/our-science/rta-1701/,http://www.jimmunol.org/content/200/1_Supplement/175.22
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/sitemap/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/legal-message/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/our-science/rta-1701/,https://twitter.com/reatapharma
https://reatapharma.com/investors-news/events-presentations/,https://twitter.com/reatapharma
https://reatapharma.com/investors-news/events-presentations/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/investors-news/events-presentations/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/investors-news/events-presentations/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/ctd-pah/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/11386927
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/24206459
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/24903467
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/25307295
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/21508635
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/21699484
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/25441438
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/25441437
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/20956520
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/19698707
https://reatapharma.com/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/,https://reatapharma.com/careers/
https://reatapharma.com/,https://reatapharma.com/contact-us/
https://reatapharma.com/,https://reatapharma.com/
https://reatapharma.com/,http://ow.ly/xiSb30l32TC
https://reatapharma.com/,https://reatapharma.com/programs
https://reatapharma.com/,https://cardinalclinicaltrial.com/
https://reatapharma.com/,https://www.moxiestudy.com/
https://reatapharma.com/,https://www.catalysttrial.com/
https://reatapharma.com/contact-us/,https://reatapharma.com/careers/
https://reatapharma.com/contact-us/,https://reatapharma.com/contact-us/
https://reatapharma.com/contact-us/,https://reatapharma.com/
https://reatapharma.com/contact-us/,"https://www.google.com/maps/dir//Reata+Pharmaceuticals,+Inc.,+2801+Gateway+Dr+#+150,+Irving,+TX+75063/@32.8946438,-97.0209935,13z/data=!4m9!4m8!1m0!1m5!1m1!1s0x864c29e7fd73004f:0xcaa3009951a9d9fa!2m2!1d-96.9858883!2d32.8946487!3e0"
https://reatapharma.com/contact-us/,https://reatapharma.com/sitemap/
https://reatapharma.com/contact-us/,https://reatapharma.com/legal-message/
https://reatapharma.com/contact-us/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/contact-us/,https://twitter.com/reatapharma
https://reatapharma.com/contact-us/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/contact-us/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/20463397
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/23951401
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/23716596
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613643/
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/23896025
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/10638762
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/10617085
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/19189297
https://reatapharma.com/about-us/board-of-directors/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/about-us/board-of-directors/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/about-us/board-of-directors/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/about-us/leadership/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/our-science/rta-901/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/our-science/rta-901/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/our-science/rta-901/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/sitemap/,https://reatapharma.com/share-your-fa-story/terms-and-conditions/
https://reatapharma.com/sitemap/,https://reatapharma.com/share-your-fa-story/thank-you/
https://reatapharma.com/sitemap/,https://reatapharma.com/share-your-fa-story/writing-tips/
https://reatapharma.com/sitemap/,https://reatapharma.com/investors-news/
https://reatapharma.com/sitemap/,https://reatapharma.com/investors-news/news-room/
https://reatapharma.com/sitemap/,https://reatapharma.com/legal-message/
https://reatapharma.com/sitemap/,https://reatapharma.com/nephrology-kol/
https://reatapharma.com/sitemap/,https://reatapharma.com/our-science/
https://reatapharma.com/our-science/rta-1701/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/our-science/rta-1701/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/our-science/rta-1701/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/26618193
https://reatapharma.com/programs/kidney-diseases/,https://academic.oup.com/ndt/article/27/suppl_2/ii11/1935265
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/16954345
https://reatapharma.com/programs/kidney-diseases/,https://www.asn-online.org/education/kidneyweek/archives/
https://reatapharma.com/programs/kidney-diseases/,https://www.sciencedirect.com/science/article/pii/0026049573902692
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/16489057
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/19371629
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/18417483
https://reatapharma.com/programs/kidney-diseases/,https://doi.org/10.1093/ndt/gfw160.01
https://reatapharma.com/,https://reatapharma.com/sitemap/
https://reatapharma.com/,https://reatapharma.com/legal-message/
https://reatapharma.com/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/,https://twitter.com/reatapharma
https://reatapharma.com/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/contact-us/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/18413762
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/17148759
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/16968214
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003357/
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752754/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/sitemap/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/legal-message/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/sitemap/,https://reatapharma.com/patients/compassionate-use-policy/
https://reatapharma.com/sitemap/,https://reatapharma.com/posts/
https://reatapharma.com/sitemap/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/iga-nephropathybard/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/immuno-oncology/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/overview/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/type-1-diabetic-ckdbard/
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/10752524
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/kidney-diseases/,https://twitter.com/reatapharma
https://reatapharma.com/programs/kidney-diseases/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/kidney-diseases/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/programs/kidney-diseases/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/our-science/nrf2-activators/,https://twitter.com/reatapharma
https://reatapharma.com/our-science/nrf2-activators/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/our-science/nrf2-activators/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/our-science/nrf2-activators/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/sitemap/,https://reatapharma.com/sitemap/
https://reatapharma.com/sitemap/,https://twitter.com/reatapharma
https://reatapharma.com/sitemap/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/sitemap/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/sitemap/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/patients/compassionate-use-policy/,http://reatapharma.wpengine.com/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,http://reatapharma.wpengine.com/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,http://reatapharma.wpengine.com/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,http://reatapharma.wpengine.com/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/programs/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/patients/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/programs/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/patients/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/patients/compassionate-use-policy/,http://www.proxydocs.com/RETA
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/programs/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/patients/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/programs/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/patients/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/careers/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/careers/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/contact-us/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/
https://reatapharma.com/patients/compassionate-use-policy/,https://clinicaltrials.gov/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/careers/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/contact-us/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,http://alportsyndrome.org/what-is-alport-syndrome/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,http://investors.reatapharma.com/phoenix.zhtml?ID=2342167&c=254306&p=irol-newsArticle
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,http://ow.ly/K7Jq30l4Pyv
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/23720336
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/careers/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/contact-us/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,http://alportsyndrome.org/what-is-alport-syndrome/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,http://investors.reatapharma.com/phoenix.zhtml?ID=2342167&c=254306&p=irol-newsArticle
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,http://ow.ly/K7Jq30l4Pyv
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/23720336
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/24195589
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/28978980
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/contact-us/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,http://alportsyndrome.org/what-is-alport-syndrome/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,http://investors.reatapharma.com/phoenix.zhtml?ID=2342167&c=254306&p=irol-newsArticle
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,http://ow.ly/K7Jq30l4Pyv
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/23720336
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/24195589
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/28978980
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600401/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/25047252
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/26612656
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/11386927
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/24206459
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/24903467
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/25307295
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/legal-message/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/patients/compassionate-use-policy/,https://twitter.com/reatapharma
https://reatapharma.com/patients/compassionate-use-policy/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/patients/compassionate-use-policy/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/patients/compassionate-use-policy/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/24195589
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/28978980
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600401/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/25047252
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/26612656
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/11386927
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/24206459
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/24903467
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/25307295
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600401/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/25047252
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/26612656
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/21508635
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/21699484
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/25441438
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/25441437
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/20956520
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/19698707
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/26618193
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://academic.oup.com/ndt/article/27/suppl_2/ii11/1935265
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/21508635
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/21699484
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/25441438
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/25441437
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/20956520
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/19698707
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/11386927
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/24206459
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/24903467
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/25307295
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/21508635
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/21699484
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/25441438
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/25441437
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/20956520
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/19698707
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/26618193
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://academic.oup.com/ndt/article/27/suppl_2/ii11/1935265
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/16954345
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.asn-online.org/education/kidneyweek/archives/
https://reatapharma.com/programs/iga-nephropathybard/,http://reatapharma.wpengine.com/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/16954345
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.asn-online.org/education/kidneyweek/archives/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.sciencedirect.com/science/article/pii/0026049573902692
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/16489057
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/19371629
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/26618193
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://academic.oup.com/ndt/article/27/suppl_2/ii11/1935265
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/16954345
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.asn-online.org/education/kidneyweek/archives/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.sciencedirect.com/science/article/pii/0026049573902692
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/16489057
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.sciencedirect.com/science/article/pii/0026049573902692
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/16489057
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/19371629
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/18417483
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://doi.org/10.1093/ndt/gfw160.01
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/10752524
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://twitter.com/reatapharma
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/programs/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/patients/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/18417483
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://doi.org/10.1093/ndt/gfw160.01
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/10752524
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://twitter.com/reatapharma
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/nephrology-kol/,http://reatapharma.wpengine.com/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/19371629
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/18417483
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://doi.org/10.1093/ndt/gfw160.01
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/10752524
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/legal-message/
https://reatapharma.com/investors-news/news-room/,http://reatapharma.wpengine.com/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/share-your-fa-story/thank-you/,https://reatapharma.com/share-your-fa-story/
https://reatapharma.com/share-your-fa-story/thank-you/,https://reatapharma.com/share-your-fa-story/writing-tips/
https://reatapharma.com/share-your-fa-story/thank-you/,https://reatapharma.com/share-your-fa-story/submission-guidelines/
https://reatapharma.com/share-your-fa-story/thank-you/,https://reatapharma.com/share-your-fa-story/terms-and-conditions/
https://reatapharma.com/share-your-fa-story/thank-you/,https://reatapharma.com/privacy-policy
https://reatapharma.com/share-your-fa-story/thank-you/,https://reatapharma.com/
https://reatapharma.com/share-your-fa-story/writing-tips/,https://reatapharma.com/share-your-fa-story/
https://reatapharma.com/share-your-fa-story/writing-tips/,https://reatapharma.com/share-your-fa-story/writing-tips/
https://reatapharma.com/share-your-fa-story/writing-tips/,https://reatapharma.com/share-your-fa-story/submission-guidelines/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/programs/iga-nephropathybard/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://twitter.com/reatapharma
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/programs/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/posts/,http://reatapharma.wpengine.com/
https://reatapharma.com/share-your-fa-story/terms-and-conditions/,https://reatapharma.com/share-your-fa-story/
https://reatapharma.com/share-your-fa-story/writing-tips/,https://reatapharma.com/share-your-fa-story/terms-and-conditions/
https://reatapharma.com/share-your-fa-story/writing-tips/,https://reatapharma.com/privacy-policy
https://reatapharma.com/share-your-fa-story/writing-tips/,https://reatapharma.com/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/careers/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/contact-us/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/
https://reatapharma.com/programs/iga-nephropathybard/,http://alportsyndrome.org/what-is-alport-syndrome/
https://reatapharma.com/programs/iga-nephropathybard/,http://investors.reatapharma.com/phoenix.zhtml?ID=2342167&c=254306&p=irol-newsArticle
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/programs/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/patients/
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/nephrology-kol/,http://www.proxydocs.com/RETA
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/patients/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/investors-news/news-room/,http://www.proxydocs.com/RETA
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/posts/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/posts/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/posts/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/posts/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/posts/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/posts/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/posts/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/posts/,https://reatapharma.com/programs/
https://reatapharma.com/posts/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/posts/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/posts/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/posts/,https://reatapharma.com/patients/
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/
https://reatapharma.com/posts/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/share-your-fa-story/terms-and-conditions/,https://reatapharma.com/share-your-fa-story/writing-tips/
https://reatapharma.com/share-your-fa-story/terms-and-conditions/,https://reatapharma.com/share-your-fa-story/submission-guidelines/
https://reatapharma.com/share-your-fa-story/terms-and-conditions/,https://reatapharma.com/privacy-policy
https://reatapharma.com/share-your-fa-story/terms-and-conditions/,http://www.fda.gov/medwatch
https://reatapharma.com/share-your-fa-story/terms-and-conditions/,https://reatapharma.com/share-your-fa-story/terms-and-conditions/
https://reatapharma.com/share-your-fa-story/terms-and-conditions/,https://reatapharma.com/
https://reatapharma.com/programs/iga-nephropathybard/,http://ow.ly/K7Jq30l4Pyv
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/23720336
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/24195589
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/28978980
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600401/
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/25047252
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/26612656
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/11386927
https://reatapharma.com/share-your-fa-story/submission-guidelines/,https://reatapharma.com/share-your-fa-story/
https://reatapharma.com/share-your-fa-story/submission-guidelines/,https://reatapharma.com/share-your-fa-story/writing-tips/
https://reatapharma.com/share-your-fa-story/submission-guidelines/,https://reatapharma.com/share-your-fa-story/submission-guidelines/
https://reatapharma.com/share-your-fa-story/submission-guidelines/,https://reatapharma.com/share-your-fa-story/terms-and-conditions/
https://reatapharma.com/share-your-fa-story/,https://reatapharma.com/share-your-fa-story/
https://reatapharma.com/share-your-fa-story/,https://reatapharma.com/share-your-fa-story/writing-tips/
https://reatapharma.com/share-your-fa-story/,https://reatapharma.com/share-your-fa-story/submission-guidelines/
https://reatapharma.com/programs/overview/,http://reatapharma.wpengine.com/
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/careers/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/careers/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/contact-us/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/sitemap/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/legal-message/
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/posts/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/posts/,http://www.proxydocs.com/RETA
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/posts/,https://reatapharma.com/careers/
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/24206459
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/24903467
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/25307295
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/21508635
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/21699484
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/25441438
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/25441437
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/20956520
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/19698707
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/26618193
https://reatapharma.com/programs/iga-nephropathybard/,https://academic.oup.com/ndt/article/27/suppl_2/ii11/1935265
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/16954345
https://reatapharma.com/programs/iga-nephropathybard/,https://www.asn-online.org/education/kidneyweek/archives/
https://reatapharma.com/programs/iga-nephropathybard/,https://www.sciencedirect.com/science/article/pii/0026049573902692
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/16489057
https://reatapharma.com/share-your-fa-story/submission-guidelines/,https://reatapharma.com/privacy-policy
https://reatapharma.com/share-your-fa-story/submission-guidelines/,https://reatapharma.com/
https://reatapharma.com/programs/immuno-oncology/,http://reatapharma.wpengine.com/
https://reatapharma.com/share-your-fa-story/,https://reatapharma.com/privacy-policy
https://reatapharma.com/share-your-fa-story/,http://www.fda.gov/medwatch
https://reatapharma.com/share-your-fa-story/,https://reatapharma.com/share-your-fa-story/terms-and-conditions
https://reatapharma.com/share-your-fa-story/,https://reatapharma.com/share-your-fa-story/submission-guidelines
https://reatapharma.com/share-your-fa-story/,https://reatapharma.com/share-your-fa-story/terms-and-conditions/
https://reatapharma.com/share-your-fa-story/,https://reatapharma.com/
https://reatapharma.com/programs/overview/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/overview/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/overview/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/programs/overview/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/overview/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/overview/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/overview/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/overview/,https://reatapharma.com/programs/
https://reatapharma.com/programs/overview/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/overview/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/overview/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/overview/,https://reatapharma.com/patients/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/contact-us/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/sitemap/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/legal-message/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/investors-news/news-room/,https://twitter.com/reatapharma
https://reatapharma.com/investors-news/news-room/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/investors-news/news-room/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/investors-news/news-room/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/posts/,https://reatapharma.com/contact-us/
https://reatapharma.com/posts/,https://reatapharma.com/
https://reatapharma.com/posts/,http://ow.ly/xiSb30l32TC
https://reatapharma.com/posts/,https://reatapharma.com/programs
https://reatapharma.com/posts/,https://reatapharma.com/sitemap/
https://reatapharma.com/posts/,https://reatapharma.com/legal-message/
https://reatapharma.com/posts/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/posts/,https://twitter.com/reatapharma
https://reatapharma.com/posts/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/posts/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/posts/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/19371629
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/18417483
https://reatapharma.com/programs/iga-nephropathybard/,https://doi.org/10.1093/ndt/gfw160.01
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/10752524
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/iga-nephropathybard/,https://twitter.com/reatapharma
https://reatapharma.com/programs/iga-nephropathybard/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/iga-nephropathybard/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/programs/iga-nephropathybard/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/programs/
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/
https://reatapharma.com/programs/overview/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/overview/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/programs/overview/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/overview/,https://reatapharma.com/careers/
https://reatapharma.com/nephrology-kol/,https://twitter.com/reatapharma
https://reatapharma.com/nephrology-kol/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/nephrology-kol/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/nephrology-kol/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/patients/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/programs/immuno-oncology/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/overview/,https://reatapharma.com/contact-us/
https://reatapharma.com/programs/overview/,https://reatapharma.com/
https://reatapharma.com/programs/overview/,https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/
https://reatapharma.com/programs/overview/,https://reatapharma.com/programs/iga-nephropathybard/
https://reatapharma.com/programs/overview/,https://reatapharma.com/programs/type-1-diabetic-ckdbard/
https://reatapharma.com/programs/overview/,https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/
https://reatapharma.com/programs/overview/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/overview/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/overview/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/overview/,https://twitter.com/reatapharma
https://reatapharma.com/programs/overview/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/overview/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/programs/overview/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/careers/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/contact-us/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/
https://reatapharma.com/programs/immuno-oncology/,https://clinicaltrials.gov/ct2/show/NCT02259231
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/product-pipeline/immuno-oncology/melanoma/
https://reatapharma.com/programs/immuno-oncology/,http://www.ncbi.nlm.nih.gov/pubmed/26091825
https://reatapharma.com/programs/immuno-oncology/,http://www.ncbi.nlm.nih.gov/pubmed/19380816
https://reatapharma.com/programs/immuno-oncology/,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2840181/
https://reatapharma.com/programs/immuno-oncology/,http://www.ncbi.nlm.nih.gov/pubmed/21911941
https://reatapharma.com/programs/immuno-oncology/,http://www.ncbi.nlm.nih.gov/pubmed/21784871
https://reatapharma.com/programs/immuno-oncology/,http://www.ncbi.nlm.nih.gov/pubmed/16557582
https://reatapharma.com/programs/immuno-oncology/,http://www.ncbi.nlm.nih.gov/pubmed/22966038
https://reatapharma.com/programs/immuno-oncology/,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405374/
https://reatapharma.com/programs/immuno-oncology/,http://www.ncbi.nlm.nih.gov/pubmed/22437870
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/immuno-oncology/,https://twitter.com/reatapharma
https://reatapharma.com/programs/immuno-oncology/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/immuno-oncology/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/programs/immuno-oncology/,https://www.instagram.com/reatapharmaceuticals/
url_from,url_to
https://reatapharma.com/about-us/our-story/,http://reatapharma.wpengine.com/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/programs/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/patients/
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/about-us/our-story/,http://www.proxydocs.com/RETA
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/careers/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/contact-us/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/
https://reatapharma.com/about-us/our-story/,https://clinicaltrials.gov/ct2/show/NCT03019185
https://reatapharma.com/about-us/our-story/,https://clinicaltrials.gov/ct2/show/NCT02657356
https://reatapharma.com/about-us/our-story/,https://clinicaltrials.gov/ct2/show/NCT03366337
https://reatapharma.com/about-us/our-story/,https://clinicaltrials.gov/ct2/show/NCT02255435
https://reatapharma.com/about-us/our-story/,http://ow.ly/K7Jq30l4Pyv
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/sitemap/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/legal-message/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/about-us/our-story/,https://twitter.com/reatapharma
https://reatapharma.com/about-us/our-story/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/about-us/our-story/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/about-us/our-story/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/sitemap/,http://reatapharma.wpengine.com/
https://reatapharma.com/careers/,http://reatapharma.wpengine.com/
https://reatapharma.com/sitemap/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/sitemap/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/sitemap/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/sitemap/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/contact-us/,http://reatapharma.wpengine.com/
https://reatapharma.com/patients/,http://reatapharma.wpengine.com/
https://reatapharma.com/,http://reatapharma.wpengine.com/
https://reatapharma.com/careers/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/careers/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/careers/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/careers/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/careers/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/sitemap/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/sitemap/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/sitemap/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/sitemap/,https://reatapharma.com/patients/
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/
https://reatapharma.com/sitemap/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/sitemap/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/sitemap/,http://www.proxydocs.com/RETA
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/contact-us/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/contact-us/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/contact-us/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/contact-us/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/contact-us/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/contact-us/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/investors-news/social-media-disclosure/,http://reatapharma.wpengine.com/
https://reatapharma.com/patients/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/patients/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/patients/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/patients/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/patients/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/,https://reatapharma.com/programs/
https://reatapharma.com/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/,https://reatapharma.com/patients/
https://reatapharma.com/,https://reatapharma.gcs-web.com/
https://reatapharma.com/careers/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/careers/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/careers/,https://reatapharma.com/programs/
https://reatapharma.com/careers/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/careers/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/careers/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/careers/,https://reatapharma.com/patients/
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/
https://reatapharma.com/careers/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/careers/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/sitemap/,https://reatapharma.com/careers/
https://reatapharma.com/sitemap/,https://reatapharma.com/contact-us/
https://reatapharma.com/sitemap/,https://reatapharma.com/
https://reatapharma.com/sitemap/,https://reatapharma.com/about-us/
https://reatapharma.com/sitemap/,https://reatapharma.com/share-your-fa-story/
https://reatapharma.com/sitemap/,https://reatapharma.com/share-your-fa-story/submission-guidelines/
https://reatapharma.com/sitemap/,https://reatapharma.com/share-your-fa-story/terms-and-conditions/
https://reatapharma.com/sitemap/,https://reatapharma.com/share-your-fa-story/thank-you/
https://reatapharma.com/investors-news/events-presentations/,http://reatapharma.wpengine.com/
https://reatapharma.com/contact-us/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/contact-us/,https://reatapharma.com/programs/
https://reatapharma.com/contact-us/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/contact-us/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/contact-us/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/contact-us/,https://reatapharma.com/patients/
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/
https://reatapharma.com/contact-us/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/patients/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/patients/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/patients/,https://reatapharma.com/programs/
https://reatapharma.com/patients/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/patients/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/patients/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/patients/,https://reatapharma.com/patients/
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/
https://reatapharma.com/patients/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/patients/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/patients/,http://www.proxydocs.com/RETA
https://reatapharma.com/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/,http://www.proxydocs.com/RETA
https://reatapharma.com/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/,https://reatapharma.com/careers/
https://reatapharma.com/,https://reatapharma.com/contact-us/
https://reatapharma.com/,https://reatapharma.com/
https://reatapharma.com/careers/,http://www.proxydocs.com/RETA
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/careers/,https://reatapharma.com/careers/
https://reatapharma.com/careers/,https://reatapharma.com/contact-us/
https://reatapharma.com/careers/,https://reatapharma.com/
https://reatapharma.com/careers/,https://reatapharma.com/sitemap/
https://reatapharma.com/careers/,https://reatapharma.com/legal-message/
https://reatapharma.com/careers/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/careers/,https://twitter.com/reatapharma
https://reatapharma.com/sitemap/,https://reatapharma.com/share-your-fa-story/writing-tips/
https://reatapharma.com/sitemap/,https://reatapharma.com/investors-news/
https://reatapharma.com/sitemap/,https://reatapharma.com/investors-news/news-room/
https://reatapharma.com/sitemap/,https://reatapharma.com/legal-message/
https://reatapharma.com/sitemap/,https://reatapharma.com/nephrology-kol/
https://reatapharma.com/sitemap/,https://reatapharma.com/our-science/
https://reatapharma.com/sitemap/,https://reatapharma.com/patients/compassionate-use-policy/
https://reatapharma.com/sitemap/,https://reatapharma.com/posts/
https://reatapharma.com/sitemap/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/iga-nephropathybard/
https://reatapharma.com/programs/,http://reatapharma.wpengine.com/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/our-science/in-licensing/,http://reatapharma.wpengine.com/
https://reatapharma.com/our-science/rta-1701/,http://reatapharma.wpengine.com/
https://reatapharma.com/contact-us/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/contact-us/,http://www.proxydocs.com/RETA
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/programs/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/patients/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/patients/,https://reatapharma.com/careers/
https://reatapharma.com/patients/,https://reatapharma.com/contact-us/
https://reatapharma.com/patients/,https://reatapharma.com/
https://reatapharma.com/patients/,https://cardinalclinicaltrial.com/
https://reatapharma.com/patients/,https://www.phoenixclinicaltrial.com/
https://reatapharma.com/patients/,https://www.moxiestudy.com/
https://reatapharma.com/patients/,https://www.catalysttrial.com/
https://reatapharma.com/,http://ow.ly/xiSb30l32TC
https://reatapharma.com/,https://reatapharma.com/programs
https://reatapharma.com/,https://cardinalclinicaltrial.com/
https://reatapharma.com/,https://www.moxiestudy.com/
https://reatapharma.com/,https://www.catalysttrial.com/
https://reatapharma.com/,https://reatapharma.com/sitemap/
https://reatapharma.com/,https://reatapharma.com/legal-message/
https://reatapharma.com/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/,https://twitter.com/reatapharma
https://reatapharma.com/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/careers/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/careers/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/careers/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/immuno-oncology/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/overview/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/type-1-diabetic-ckdbard/
https://reatapharma.com/sitemap/,https://reatapharma.com/sitemap/
https://reatapharma.com/sitemap/,https://twitter.com/reatapharma
https://reatapharma.com/sitemap/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/sitemap/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/sitemap/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/programs/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/,https://reatapharma.com/programs/
https://reatapharma.com/programs/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/ctd-pah/,http://reatapharma.wpengine.com/
https://reatapharma.com/programs/friedreichs-ataxia/,http://reatapharma.wpengine.com/
https://reatapharma.com/programs/kidney-diseases/,http://reatapharma.wpengine.com/
https://reatapharma.com/our-science/rta-901/,http://reatapharma.wpengine.com/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/programs/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/patients/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/programs/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/patients/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/privacy-policy/,http://reatapharma.wpengine.com/
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/contact-us/,https://reatapharma.com/careers/
https://reatapharma.com/contact-us/,https://reatapharma.com/contact-us/
https://reatapharma.com/contact-us/,https://reatapharma.com/
https://reatapharma.com/contact-us/,"https://www.google.com/maps/dir//Reata+Pharmaceuticals,+Inc.,+2801+Gateway+Dr+#+150,+Irving,+TX+75063/@32.8946438,-97.0209935,13z/data=!4m9!4m8!1m0!1m5!1m1!1s0x864c29e7fd73004f:0xcaa3009951a9d9fa!2m2!1d-96.9858883!2d32.8946487!3e0"
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/investors-news/social-media-disclosure/,http://www.proxydocs.com/RETA
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/patients/,https://reatapharma.com/patients/compassionate-use-policy/
https://reatapharma.com/patients/,https://reatapharma.wpengine.com/patients/compassionate-use-policy/
https://reatapharma.com/patients/,https://reatapharma.com/sitemap/
https://reatapharma.com/patients/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/,https://reatapharma.com/patients/
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/
https://reatapharma.com/programs/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/programs/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/programs/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/programs/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/programs/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/patients/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/programs/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/patients/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/programs/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/patients/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/investors-news/events-presentations/,http://www.proxydocs.com/RETA
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/our-science/in-licensing/,http://www.proxydocs.com/RETA
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/careers/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/contact-us/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/sitemap/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/our-science/rta-1701/,http://www.proxydocs.com/RETA
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/careers/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/contact-us/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/
https://reatapharma.com/our-science/rta-1701/,https://www.ncbi.nlm.nih.gov/pubmed/19076351
https://reatapharma.com/our-science/rta-1701/,https://www.ncbi.nlm.nih.gov/pubmed/26388774
https://reatapharma.com/our-science/rta-1701/,http://www.autoimmuneregistry.org/autoimmune-statistics/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/programs/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/patients/
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/contact-us/,https://reatapharma.com/sitemap/
https://reatapharma.com/contact-us/,https://reatapharma.com/legal-message/
https://reatapharma.com/contact-us/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/contact-us/,https://twitter.com/reatapharma
https://reatapharma.com/contact-us/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/contact-us/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/contact-us/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/careers/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/contact-us/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/
https://reatapharma.com/patients/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/patients/,https://twitter.com/reatapharma
https://reatapharma.com/patients/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/patients/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/patients/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/,https://reatapharma.com/careers/
https://reatapharma.com/programs/,https://reatapharma.com/contact-us/
https://reatapharma.com/programs/,https://reatapharma.com/
https://reatapharma.com/programs/,https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/
https://reatapharma.com/programs/,https://reatapharma.com/programs/iga-nephropathybard/
https://reatapharma.com/programs/,https://reatapharma.com/programs/type-1-diabetic-ckdbard/
https://reatapharma.com/programs/,https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/
https://reatapharma.com/programs/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/,https://twitter.com/reatapharma
https://reatapharma.com/programs/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/legal-message/,http://reatapharma.wpengine.com/
https://reatapharma.com/about-us/leadership/,http://reatapharma.wpengine.com/
https://reatapharma.com/our-science/nrf2-activators/,http://reatapharma.wpengine.com/
https://reatapharma.com/about-us/board-of-directors/,http://reatapharma.wpengine.com/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/patients/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/patients/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/programs/kidney-diseases/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/our-science/rta-901/,http://www.proxydocs.com/RETA
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/careers/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/careers/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/contact-us/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/
https://reatapharma.com/investors-news/events-presentations/,http://ow.ly/xiSb30l32TC
https://reatapharma.com/investors-news/events-presentations/,https://clinicaltrials.gov/ct2/show/NCT02036970
https://reatapharma.com/investors-news/events-presentations/,https://clinicaltrials.gov/ct2/show/NCT02657356
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/sitemap/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/legal-message/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/legal-message/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/our-science/in-licensing/,https://twitter.com/reatapharma
https://reatapharma.com/our-science/in-licensing/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/our-science/in-licensing/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/our-science/in-licensing/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/our-science/rta-1701/,https://www.ncbi.nlm.nih.gov/pubmed/21081189
https://reatapharma.com/our-science/rta-1701/,http://www.jimmunol.org/content/200/1_Supplement/121.14
https://reatapharma.com/our-science/rta-1701/,http://www.jimmunol.org/content/200/1_Supplement/175.22
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/sitemap/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/legal-message/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/our-science/rta-1701/,https://twitter.com/reatapharma
https://reatapharma.com/our-science/rta-1701/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/our-science/rta-1701/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/our-science/rta-1701/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/privacy-policy/,http://www.proxydocs.com/RETA
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/investors-news/social-media-disclosure/,https://twitter.com/reatapharma
https://reatapharma.com/investors-news/social-media-disclosure/,https://www.linkedin.com/company/reata-pharmaceuticals
https://reatapharma.com/investors-news/social-media-disclosure/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/investors-news/social-media-disclosure/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/sitemap/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/legal-message/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/investors-news/social-media-disclosure/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/legal-message/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/legal-message/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/legal-message/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/legal-message/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/legal-message/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/legal-message/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/legal-message/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/legal-message/,https://reatapharma.com/programs/
https://reatapharma.com/legal-message/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/legal-message/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/legal-message/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/legal-message/,https://reatapharma.com/patients/
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/programs/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/programs/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/patients/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/programs/ctd-pah/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/careers/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/contact-us/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/careers/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/contact-us/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/
https://reatapharma.com/programs/friedreichs-ataxia/,https://clinicaltrials.gov/ct2/show/NCT02255435
https://reatapharma.com/programs/friedreichs-ataxia/,http://ow.ly/K7Jq30l4Pyv
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/19347027
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/23859338
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/careers/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/contact-us/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/
https://reatapharma.com/programs/kidney-diseases/,http://alportsyndrome.org/what-is-alport-syndrome/
https://reatapharma.com/programs/kidney-diseases/,http://investors.reatapharma.com/phoenix.zhtml?ID=2342167&c=254306&p=irol-newsArticle
https://reatapharma.com/programs/kidney-diseases/,http://ow.ly/K7Jq30l4Pyv
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/23720336
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/24195589
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/28978980
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600401/
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/25047252
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/26612656
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/11386927
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/24206459
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/contact-us/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/
https://reatapharma.com/our-science/rta-901/,http://www.ncbi.nlm.nih.gov/pubmed/20955164
https://reatapharma.com/our-science/rta-901/,http://www.ncbi.nlm.nih.gov/pubmed/17656567
https://reatapharma.com/our-science/rta-901/,http://www.ncbi.nlm.nih.gov/pubmed/10605935
https://reatapharma.com/our-science/rta-901/,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049350/
https://reatapharma.com/our-science/rta-901/,http://www.ncbi.nlm.nih.gov/pubmed/24263156
https://reatapharma.com/our-science/rta-901/,https://kuscholarworks.ku.edu/handle/1808/10216
https://reatapharma.com/our-science/rta-901/,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517131/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/sitemap/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/legal-message/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/our-science/rta-901/,https://twitter.com/reatapharma
https://reatapharma.com/our-science/rta-901/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/our-science/rta-901/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/our-science/rta-901/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/investors-news/events-presentations/,https://twitter.com/reatapharma
https://reatapharma.com/investors-news/events-presentations/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/investors-news/events-presentations/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/investors-news/events-presentations/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/careers/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/contact-us/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/
https://reatapharma.com/privacy-policy/,https://reatapharma.wpengine.com/
https://reatapharma.com/privacy-policy/,https://www.consumer.ftc.gov/topics/protecting-kids-online
https://reatapharma.com/privacy-policy/,https://reatapharma.com/sitemap/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/legal-message/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/privacy-policy/,https://twitter.com/reatapharma
https://reatapharma.com/privacy-policy/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/privacy-policy/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/privacy-policy/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/legal-message/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/legal-message/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/legal-message/,http://www.proxydocs.com/RETA
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/programs/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/patients/
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/patients/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/our-science/nrf2-activators/,http://www.proxydocs.com/RETA
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/about-us/board-of-directors/,http://www.proxydocs.com/RETA
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/careers/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/contact-us/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/
https://reatapharma.com/programs/ctd-pah/,https://clinicaltrials.gov/ct2/show/NCT02657356
https://reatapharma.com/programs/ctd-pah/,http://ow.ly/K7Jq30l4Pyv
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/19837821
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/24355642
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/16218473
https://reatapharma.com/programs/ctd-pah/,https://www.ncbi.nlm.nih.gov/pubmed/24709277
https://reatapharma.com/programs/ctd-pah/,https://www.ncbi.nlm.nih.gov/pubmed/26669915
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/23983198
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/16496078
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/22281797
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/19282344
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/26291092
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/20507945
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/21457778
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/19720606
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/23859346
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/9577387
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/20156111
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/21550666
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/10319894
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/10500204
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/23350650
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/23574943
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/19158945
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/23951401
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/24903467
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/25307295
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/21508635
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/21699484
https://reatapharma.com/legal-message/,https://reatapharma.com/careers/
https://reatapharma.com/legal-message/,https://reatapharma.com/contact-us/
https://reatapharma.com/legal-message/,https://reatapharma.com/
https://reatapharma.com/legal-message/,https://reatapharma.com/privacy-policy
https://reatapharma.com/legal-message/,https://reatapharma.com/sitemap/
https://reatapharma.com/legal-message/,https://reatapharma.com/legal-message/
https://reatapharma.com/legal-message/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/legal-message/,https://twitter.com/reatapharma
https://reatapharma.com/legal-message/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/legal-message/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/legal-message/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/about-us/leadership/,http://www.proxydocs.com/RETA
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/careers/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/contact-us/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179323/
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/23311665
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/22966038
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/20463397
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/23951401
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/sitemap/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/legal-message/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/about-us/board-of-directors/,https://twitter.com/reatapharma
https://reatapharma.com/about-us/board-of-directors/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/about-us/board-of-directors/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/about-us/board-of-directors/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/23741300
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/25926128
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/18065492
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/17363558
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/ctd-pah/,https://twitter.com/reatapharma
https://reatapharma.com/programs/ctd-pah/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/friedreichs-ataxia/,https://twitter.com/reatapharma
https://reatapharma.com/programs/friedreichs-ataxia/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/friedreichs-ataxia/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/programs/friedreichs-ataxia/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/25441438
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/25441437
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/20956520
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/19698707
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/26618193
https://reatapharma.com/programs/kidney-diseases/,https://academic.oup.com/ndt/article/27/suppl_2/ii11/1935265
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/16954345
https://reatapharma.com/programs/kidney-diseases/,https://www.asn-online.org/education/kidneyweek/archives/
https://reatapharma.com/programs/kidney-diseases/,https://www.sciencedirect.com/science/article/pii/0026049573902692
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/16489057
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/19371629
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,http://reatapharma.wpengine.com/
https://reatapharma.com/programs/overview/,http://reatapharma.wpengine.com/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/careers/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/contact-us/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/sitemap/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/immuno-oncology/,http://reatapharma.wpengine.com/
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/23716596
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613643/
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/23896025
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/10638762
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/10617085
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/19189297
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/18413762
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/17148759
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/16968214
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003357/
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752754/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/sitemap/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,http://reatapharma.wpengine.com/
https://reatapharma.com/programs/iga-nephropathybard/,http://reatapharma.wpengine.com/
https://reatapharma.com/posts/,http://reatapharma.wpengine.com/
https://reatapharma.com/programs/ctd-pah/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/programs/ctd-pah/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/patients/compassionate-use-policy/,http://reatapharma.wpengine.com/
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/18417483
https://reatapharma.com/programs/kidney-diseases/,https://doi.org/10.1093/ndt/gfw160.01
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/10752524
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/kidney-diseases/,https://twitter.com/reatapharma
https://reatapharma.com/programs/kidney-diseases/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/kidney-diseases/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/programs/kidney-diseases/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/programs/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/patients/
https://reatapharma.com/programs/overview/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/overview/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/overview/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/programs/overview/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/overview/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/overview/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/overview/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/overview/,https://reatapharma.com/programs/
https://reatapharma.com/programs/overview/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/overview/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/overview/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/overview/,https://reatapharma.com/patients/
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/
https://reatapharma.com/programs/overview/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/about-us/leadership/,https://twitter.com/reatapharma
https://reatapharma.com/about-us/leadership/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/about-us/leadership/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/about-us/leadership/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/our-science/nrf2-activators/,https://twitter.com/reatapharma
https://reatapharma.com/our-science/nrf2-activators/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/our-science/nrf2-activators/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/our-science/nrf2-activators/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/programs/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/programs/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/programs/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/posts/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/posts/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/posts/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/posts/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/posts/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/posts/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/posts/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/programs/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,http://reatapharma.wpengine.com/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/overview/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/programs/overview/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/overview/,https://reatapharma.com/careers/
https://reatapharma.com/programs/overview/,https://reatapharma.com/contact-us/
https://reatapharma.com/programs/overview/,https://reatapharma.com/
https://reatapharma.com/nephrology-kol/,http://reatapharma.wpengine.com/
https://reatapharma.com/share-your-fa-story/writing-tips/,https://reatapharma.com/share-your-fa-story/
https://reatapharma.com/share-your-fa-story/writing-tips/,https://reatapharma.com/share-your-fa-story/writing-tips/
https://reatapharma.com/share-your-fa-story/writing-tips/,https://reatapharma.com/share-your-fa-story/submission-guidelines/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/patients/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/share-your-fa-story/thank-you/,https://reatapharma.com/share-your-fa-story/
https://reatapharma.com/share-your-fa-story/thank-you/,https://reatapharma.com/share-your-fa-story/writing-tips/
https://reatapharma.com/share-your-fa-story/terms-and-conditions/,https://reatapharma.com/share-your-fa-story/
https://reatapharma.com/share-your-fa-story/terms-and-conditions/,https://reatapharma.com/share-your-fa-story/writing-tips/
https://reatapharma.com/share-your-fa-story/terms-and-conditions/,https://reatapharma.com/share-your-fa-story/submission-guidelines/
https://reatapharma.com/share-your-fa-story/terms-and-conditions/,https://reatapharma.com/privacy-policy
https://reatapharma.com/share-your-fa-story/terms-and-conditions/,http://www.fda.gov/medwatch
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/patients/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/patients/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/programs/iga-nephropathybard/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/posts/,https://reatapharma.com/programs/
https://reatapharma.com/posts/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/posts/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/posts/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/posts/,https://reatapharma.com/patients/
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/
https://reatapharma.com/posts/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/posts/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/posts/,http://www.proxydocs.com/RETA
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/patients/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/patients/compassionate-use-policy/,http://www.proxydocs.com/RETA
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/programs/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/careers/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/contact-us/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,http://alportsyndrome.org/what-is-alport-syndrome/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,http://investors.reatapharma.com/phoenix.zhtml?ID=2342167&c=254306&p=irol-newsArticle
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,http://ow.ly/K7Jq30l4Pyv
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/23720336
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/24195589
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/28978980
https://reatapharma.com/programs/overview/,https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/
https://reatapharma.com/programs/overview/,https://reatapharma.com/programs/iga-nephropathybard/
https://reatapharma.com/programs/overview/,https://reatapharma.com/programs/type-1-diabetic-ckdbard/
https://reatapharma.com/programs/overview/,https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/
https://reatapharma.com/programs/overview/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/overview/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/overview/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/overview/,https://twitter.com/reatapharma
https://reatapharma.com/programs/overview/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/overview/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/programs/overview/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/programs/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/patients/
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/share-your-fa-story/writing-tips/,https://reatapharma.com/share-your-fa-story/terms-and-conditions/
https://reatapharma.com/share-your-fa-story/writing-tips/,https://reatapharma.com/privacy-policy
https://reatapharma.com/share-your-fa-story/writing-tips/,https://reatapharma.com/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/programs/immuno-oncology/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/careers/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/contact-us/
https://reatapharma.com/share-your-fa-story/thank-you/,https://reatapharma.com/share-your-fa-story/submission-guidelines/
https://reatapharma.com/share-your-fa-story/thank-you/,https://reatapharma.com/share-your-fa-story/terms-and-conditions/
https://reatapharma.com/share-your-fa-story/thank-you/,https://reatapharma.com/privacy-policy
https://reatapharma.com/share-your-fa-story/thank-you/,https://reatapharma.com/
https://reatapharma.com/share-your-fa-story/terms-and-conditions/,https://reatapharma.com/share-your-fa-story/terms-and-conditions/
https://reatapharma.com/share-your-fa-story/terms-and-conditions/,https://reatapharma.com/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/careers/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/contact-us/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,http://alportsyndrome.org/what-is-alport-syndrome/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,http://investors.reatapharma.com/phoenix.zhtml?ID=2342167&c=254306&p=irol-newsArticle
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/careers/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/contact-us/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/
https://reatapharma.com/programs/iga-nephropathybard/,http://alportsyndrome.org/what-is-alport-syndrome/
https://reatapharma.com/programs/iga-nephropathybard/,http://investors.reatapharma.com/phoenix.zhtml?ID=2342167&c=254306&p=irol-newsArticle
https://reatapharma.com/programs/iga-nephropathybard/,http://ow.ly/K7Jq30l4Pyv
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/23720336
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/24195589
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/posts/,https://reatapharma.com/careers/
https://reatapharma.com/posts/,https://reatapharma.com/contact-us/
https://reatapharma.com/posts/,https://reatapharma.com/
https://reatapharma.com/posts/,http://ow.ly/xiSb30l32TC
https://reatapharma.com/posts/,https://reatapharma.com/programs
https://reatapharma.com/posts/,https://reatapharma.com/sitemap/
https://reatapharma.com/posts/,https://reatapharma.com/legal-message/
https://reatapharma.com/posts/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/posts/,https://twitter.com/reatapharma
https://reatapharma.com/posts/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/posts/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/posts/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/careers/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/contact-us/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/
https://reatapharma.com/patients/compassionate-use-policy/,https://clinicaltrials.gov/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/sitemap/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/legal-message/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/patients/compassionate-use-policy/,https://twitter.com/reatapharma
https://reatapharma.com/patients/compassionate-use-policy/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/patients/compassionate-use-policy/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/patients/compassionate-use-policy/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/patients/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600401/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/25047252
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/26612656
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/11386927
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/24206459
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/24903467
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/25307295
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/21508635
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/21699484
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/25441438
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/25441437
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/nephrology-kol/,http://www.proxydocs.com/RETA
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/
https://reatapharma.com/programs/immuno-oncology/,https://clinicaltrials.gov/ct2/show/NCT02259231
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/product-pipeline/immuno-oncology/melanoma/
https://reatapharma.com/programs/immuno-oncology/,http://www.ncbi.nlm.nih.gov/pubmed/26091825
https://reatapharma.com/programs/immuno-oncology/,http://www.ncbi.nlm.nih.gov/pubmed/19380816
https://reatapharma.com/programs/immuno-oncology/,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2840181/
https://reatapharma.com/programs/immuno-oncology/,http://www.ncbi.nlm.nih.gov/pubmed/21911941
https://reatapharma.com/programs/immuno-oncology/,http://www.ncbi.nlm.nih.gov/pubmed/21784871
https://reatapharma.com/programs/immuno-oncology/,http://www.ncbi.nlm.nih.gov/pubmed/16557582
https://reatapharma.com/programs/immuno-oncology/,http://www.ncbi.nlm.nih.gov/pubmed/22966038
https://reatapharma.com/share-your-fa-story/,https://reatapharma.com/share-your-fa-story/
https://reatapharma.com/share-your-fa-story/,https://reatapharma.com/share-your-fa-story/writing-tips/
https://reatapharma.com/share-your-fa-story/,https://reatapharma.com/share-your-fa-story/submission-guidelines/
https://reatapharma.com/share-your-fa-story/,https://reatapharma.com/privacy-policy
https://reatapharma.com/share-your-fa-story/,http://www.fda.gov/medwatch
https://reatapharma.com/share-your-fa-story/,https://reatapharma.com/share-your-fa-story/terms-and-conditions
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,http://ow.ly/K7Jq30l4Pyv
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/23720336
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/24195589
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/28978980
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600401/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/25047252
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/26612656
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/11386927
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/28978980
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600401/
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/25047252
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/26612656
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/11386927
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/24206459
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/24903467
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/25307295
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/21508635
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/21699484
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/25441438
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/25441437
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/20956520
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/19698707
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/26618193
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/careers/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/contact-us/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,http://alportsyndrome.org/what-is-alport-syndrome/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,http://investors.reatapharma.com/phoenix.zhtml?ID=2342167&c=254306&p=irol-newsArticle
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/20956520
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/19698707
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/26618193
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://academic.oup.com/ndt/article/27/suppl_2/ii11/1935265
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/16954345
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.asn-online.org/education/kidneyweek/archives/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.sciencedirect.com/science/article/pii/0026049573902692
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/16489057
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/19371629
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/18417483
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://doi.org/10.1093/ndt/gfw160.01
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/10752524
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/legal-message/
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/careers/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/contact-us/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/sitemap/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/legal-message/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/nephrology-kol/,https://twitter.com/reatapharma
https://reatapharma.com/nephrology-kol/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/nephrology-kol/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/nephrology-kol/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/immuno-oncology/,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405374/
https://reatapharma.com/programs/immuno-oncology/,http://www.ncbi.nlm.nih.gov/pubmed/22437870
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/immuno-oncology/,https://twitter.com/reatapharma
https://reatapharma.com/programs/immuno-oncology/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/immuno-oncology/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/programs/immuno-oncology/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/share-your-fa-story/,https://reatapharma.com/share-your-fa-story/submission-guidelines
https://reatapharma.com/share-your-fa-story/,https://reatapharma.com/share-your-fa-story/terms-and-conditions/
https://reatapharma.com/share-your-fa-story/,https://reatapharma.com/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/24206459
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/24903467
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/25307295
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/21508635
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/21699484
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/25441438
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/25441437
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/20956520
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/19698707
https://reatapharma.com/programs/iga-nephropathybard/,https://academic.oup.com/ndt/article/27/suppl_2/ii11/1935265
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/16954345
https://reatapharma.com/programs/iga-nephropathybard/,https://www.asn-online.org/education/kidneyweek/archives/
https://reatapharma.com/programs/iga-nephropathybard/,https://www.sciencedirect.com/science/article/pii/0026049573902692
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/16489057
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/19371629
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/18417483
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,http://ow.ly/K7Jq30l4Pyv
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/23720336
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/24195589
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/28978980
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600401/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/25047252
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/26612656
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/11386927
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/24206459
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://twitter.com/reatapharma
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/26618193
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://academic.oup.com/ndt/article/27/suppl_2/ii11/1935265
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/16954345
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.asn-online.org/education/kidneyweek/archives/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.sciencedirect.com/science/article/pii/0026049573902692
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/16489057
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/19371629
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/18417483
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://doi.org/10.1093/ndt/gfw160.01
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/10752524
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/iga-nephropathybard/,https://doi.org/10.1093/ndt/gfw160.01
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/10752524
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/iga-nephropathybard/,https://twitter.com/reatapharma
https://reatapharma.com/programs/iga-nephropathybard/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/iga-nephropathybard/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/programs/iga-nephropathybard/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/24903467
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/25307295
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/21508635
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/21699484
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/25441438
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/25441437
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/20956520
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/19698707
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/26618193
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://twitter.com/reatapharma
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://academic.oup.com/ndt/article/27/suppl_2/ii11/1935265
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/16954345
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.asn-online.org/education/kidneyweek/archives/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.sciencedirect.com/science/article/pii/0026049573902692
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/16489057
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/19371629
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/18417483
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://doi.org/10.1093/ndt/gfw160.01
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/10752524
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://twitter.com/reatapharma
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/share-your-fa-story/submission-guidelines/,https://reatapharma.com/share-your-fa-story/
https://reatapharma.com/share-your-fa-story/submission-guidelines/,https://reatapharma.com/share-your-fa-story/writing-tips/
https://reatapharma.com/share-your-fa-story/submission-guidelines/,https://reatapharma.com/share-your-fa-story/submission-guidelines/
https://reatapharma.com/share-your-fa-story/submission-guidelines/,https://reatapharma.com/share-your-fa-story/terms-and-conditions/
https://reatapharma.com/investors-news/news-room/,http://reatapharma.wpengine.com/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/share-your-fa-story/submission-guidelines/,https://reatapharma.com/privacy-policy
https://reatapharma.com/share-your-fa-story/submission-guidelines/,https://reatapharma.com/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/programs/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/patients/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/investors-news/news-room/,http://www.proxydocs.com/RETA
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/careers/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/contact-us/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/sitemap/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/legal-message/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/investors-news/news-room/,https://twitter.com/reatapharma
https://reatapharma.com/investors-news/news-room/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/investors-news/news-room/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/investors-news/news-room/,https://www.instagram.com/reatapharmaceuticals/
url_from,url_to
https://reatapharma.com/about-us/our-story/,http://reatapharma.wpengine.com/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/programs/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/patients/
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/about-us/our-story/,http://www.proxydocs.com/RETA
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/about-us/our-story/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/careers/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/contact-us/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/
https://reatapharma.com/about-us/our-story/,https://clinicaltrials.gov/ct2/show/NCT03019185
https://reatapharma.com/about-us/our-story/,https://clinicaltrials.gov/ct2/show/NCT02657356
https://reatapharma.com/about-us/our-story/,https://clinicaltrials.gov/ct2/show/NCT03366337
https://reatapharma.com/about-us/our-story/,https://clinicaltrials.gov/ct2/show/NCT02255435
https://reatapharma.com/about-us/our-story/,http://ow.ly/K7Jq30l4Pyv
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/sitemap/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/legal-message/
https://reatapharma.com/about-us/our-story/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/about-us/our-story/,https://twitter.com/reatapharma
https://reatapharma.com/about-us/our-story/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/about-us/our-story/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/about-us/our-story/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/,http://reatapharma.wpengine.com/
https://reatapharma.com/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/,https://reatapharma.com/programs/
https://reatapharma.com/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/,https://reatapharma.com/patients/
https://reatapharma.com/,https://reatapharma.gcs-web.com/
https://reatapharma.com/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/,http://www.proxydocs.com/RETA
https://reatapharma.com/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/,https://reatapharma.com/careers/
https://reatapharma.com/,https://reatapharma.com/contact-us/
https://reatapharma.com/,https://reatapharma.com/
https://reatapharma.com/,http://ow.ly/xiSb30l32TC
https://reatapharma.com/,https://reatapharma.com/programs
https://reatapharma.com/,https://cardinalclinicaltrial.com/
https://reatapharma.com/,https://www.moxiestudy.com/
https://reatapharma.com/,https://www.catalysttrial.com/
https://reatapharma.com/,https://reatapharma.com/sitemap/
https://reatapharma.com/,https://reatapharma.com/legal-message/
https://reatapharma.com/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/,https://twitter.com/reatapharma
https://reatapharma.com/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/investors-news/social-media-disclosure/,http://reatapharma.wpengine.com/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/programs/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/patients/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/investors-news/social-media-disclosure/,http://www.proxydocs.com/RETA
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/careers/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/contact-us/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/
https://reatapharma.com/investors-news/social-media-disclosure/,https://twitter.com/reatapharma
https://reatapharma.com/investors-news/social-media-disclosure/,https://www.linkedin.com/company/reata-pharmaceuticals
https://reatapharma.com/investors-news/social-media-disclosure/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/investors-news/social-media-disclosure/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/sitemap/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/legal-message/
https://reatapharma.com/investors-news/social-media-disclosure/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/investors-news/social-media-disclosure/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/legal-message/,http://reatapharma.wpengine.com/
https://reatapharma.com/legal-message/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/legal-message/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/legal-message/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/legal-message/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/legal-message/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/legal-message/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/legal-message/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/legal-message/,https://reatapharma.com/programs/
https://reatapharma.com/legal-message/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/legal-message/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/legal-message/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/legal-message/,https://reatapharma.com/patients/
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/
https://reatapharma.com/legal-message/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/legal-message/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/legal-message/,http://www.proxydocs.com/RETA
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/legal-message/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/legal-message/,https://reatapharma.com/careers/
https://reatapharma.com/legal-message/,https://reatapharma.com/contact-us/
https://reatapharma.com/legal-message/,https://reatapharma.com/
https://reatapharma.com/legal-message/,https://reatapharma.com/privacy-policy
https://reatapharma.com/legal-message/,https://reatapharma.com/sitemap/
https://reatapharma.com/legal-message/,https://reatapharma.com/legal-message/
https://reatapharma.com/legal-message/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/legal-message/,https://twitter.com/reatapharma
https://reatapharma.com/legal-message/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/legal-message/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/legal-message/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/careers/,http://reatapharma.wpengine.com/
https://reatapharma.com/careers/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/careers/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/careers/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/careers/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/careers/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/careers/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/careers/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/careers/,https://reatapharma.com/programs/
https://reatapharma.com/sitemap/,http://reatapharma.wpengine.com/
https://reatapharma.com/careers/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/careers/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/careers/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/careers/,https://reatapharma.com/patients/
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/
https://reatapharma.com/careers/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/careers/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/careers/,http://www.proxydocs.com/RETA
https://reatapharma.com/sitemap/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/sitemap/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/sitemap/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/sitemap/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/sitemap/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/sitemap/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/sitemap/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/contact-us/,http://reatapharma.wpengine.com/
https://reatapharma.com/sitemap/,https://reatapharma.com/patients/
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/
https://reatapharma.com/sitemap/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/sitemap/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/privacy-policy/,http://reatapharma.wpengine.com/
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/careers/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/careers/,https://reatapharma.com/careers/
https://reatapharma.com/careers/,https://reatapharma.com/contact-us/
https://reatapharma.com/careers/,https://reatapharma.com/
https://reatapharma.com/careers/,https://reatapharma.com/sitemap/
https://reatapharma.com/careers/,https://reatapharma.com/legal-message/
https://reatapharma.com/careers/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/contact-us/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/contact-us/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/contact-us/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/contact-us/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/contact-us/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/contact-us/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/contact-us/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/contact-us/,https://reatapharma.com/programs/
https://reatapharma.com/contact-us/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/contact-us/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/sitemap/,http://www.proxydocs.com/RETA
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/sitemap/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/privacy-policy/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/careers/,https://twitter.com/reatapharma
https://reatapharma.com/careers/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/careers/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/careers/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/contact-us/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/contact-us/,https://reatapharma.com/patients/
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/
https://reatapharma.com/contact-us/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/contact-us/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/sitemap/,https://reatapharma.com/careers/
https://reatapharma.com/sitemap/,https://reatapharma.com/contact-us/
https://reatapharma.com/sitemap/,https://reatapharma.com/
https://reatapharma.com/sitemap/,https://reatapharma.com/about-us/
https://reatapharma.com/sitemap/,https://reatapharma.com/share-your-fa-story/
https://reatapharma.com/sitemap/,https://reatapharma.com/share-your-fa-story/submission-guidelines/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/programs/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/patients/
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/contact-us/,http://www.proxydocs.com/RETA
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/contact-us/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/contact-us/,https://reatapharma.com/careers/
https://reatapharma.com/contact-us/,https://reatapharma.com/contact-us/
https://reatapharma.com/contact-us/,https://reatapharma.com/
https://reatapharma.com/contact-us/,"https://www.google.com/maps/dir//Reata+Pharmaceuticals,+Inc.,+2801+Gateway+Dr+#+150,+Irving,+TX+75063/@32.8946438,-97.0209935,13z/data=!4m9!4m8!1m0!1m5!1m1!1s0x864c29e7fd73004f:0xcaa3009951a9d9fa!2m2!1d-96.9858883!2d32.8946487!3e0"
https://reatapharma.com/contact-us/,https://reatapharma.com/sitemap/
https://reatapharma.com/sitemap/,https://reatapharma.com/share-your-fa-story/terms-and-conditions/
https://reatapharma.com/sitemap/,https://reatapharma.com/share-your-fa-story/thank-you/
https://reatapharma.com/sitemap/,https://reatapharma.com/share-your-fa-story/writing-tips/
https://reatapharma.com/sitemap/,https://reatapharma.com/investors-news/
https://reatapharma.com/sitemap/,https://reatapharma.com/investors-news/news-room/
https://reatapharma.com/sitemap/,https://reatapharma.com/legal-message/
https://reatapharma.com/sitemap/,https://reatapharma.com/nephrology-kol/
https://reatapharma.com/sitemap/,https://reatapharma.com/our-science/
https://reatapharma.com/sitemap/,https://reatapharma.com/patients/compassionate-use-policy/
https://reatapharma.com/sitemap/,https://reatapharma.com/posts/
https://reatapharma.com/sitemap/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/privacy-policy/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/privacy-policy/,http://www.proxydocs.com/RETA
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/contact-us/,https://reatapharma.com/legal-message/
https://reatapharma.com/contact-us/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/contact-us/,https://twitter.com/reatapharma
https://reatapharma.com/contact-us/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/contact-us/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/contact-us/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/iga-nephropathybard/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/immuno-oncology/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/overview/
https://reatapharma.com/sitemap/,https://reatapharma.com/programs/type-1-diabetic-ckdbard/
https://reatapharma.com/sitemap/,https://reatapharma.com/sitemap/
https://reatapharma.com/sitemap/,https://reatapharma.com/thank-you-for-your-interest/
https://reatapharma.com/sitemap/,https://twitter.com/reatapharma
https://reatapharma.com/sitemap/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/privacy-policy/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/privacy-policy/,https://reatapharma.com/careers/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/contact-us/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/
https://reatapharma.com/privacy-policy/,https://reatapharma.wpengine.com/
https://reatapharma.com/privacy-policy/,https://www.consumer.ftc.gov/topics/protecting-kids-online
https://reatapharma.com/privacy-policy/,https://reatapharma.com/sitemap/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/legal-message/
https://reatapharma.com/privacy-policy/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/ctd-pah/,http://reatapharma.wpengine.com/
https://reatapharma.com/programs/friedreichs-ataxia/,http://reatapharma.wpengine.com/
https://reatapharma.com/sitemap/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/sitemap/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/privacy-policy/,https://twitter.com/reatapharma
https://reatapharma.com/privacy-policy/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/privacy-policy/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/privacy-policy/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/programs/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/investors-news/events-presentations/,http://reatapharma.wpengine.com/
https://reatapharma.com/our-science/in-licensing/,http://reatapharma.wpengine.com/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/programs/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/patients/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.proxydocs.com/RETA
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/programs/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/programs/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/patients/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/kidney-diseases/,http://reatapharma.wpengine.com/
https://reatapharma.com/patients/,http://reatapharma.wpengine.com/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/patients/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/our-science/rta-1701/,http://reatapharma.wpengine.com/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/patients/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/programs/ctd-pah/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/careers/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/contact-us/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/
https://reatapharma.com/programs/friedreichs-ataxia/,https://clinicaltrials.gov/ct2/show/NCT02255435
https://reatapharma.com/programs/friedreichs-ataxia/,http://ow.ly/K7Jq30l4Pyv
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/19347027
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/programs/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/patients/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/
https://reatapharma.com/patients/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/patients/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/patients/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/patients/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/patients/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/patients/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/patients/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/patients/,https://reatapharma.com/programs/
https://reatapharma.com/patients/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/patients/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/patients/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/patients/,https://reatapharma.com/patients/
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/
https://reatapharma.com/patients/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/patients/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/investors-news/events-presentations/,http://www.proxydocs.com/RETA
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/careers/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/contact-us/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/
https://reatapharma.com/investors-news/events-presentations/,http://ow.ly/xiSb30l32TC
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/programs/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/our-science/in-licensing/,http://www.proxydocs.com/RETA
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/careers/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/contact-us/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/
https://reatapharma.com/programs/ctd-pah/,https://clinicaltrials.gov/ct2/show/NCT02657356
https://reatapharma.com/programs/ctd-pah/,http://ow.ly/K7Jq30l4Pyv
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/19837821
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/24355642
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/16218473
https://reatapharma.com/programs/ctd-pah/,https://www.ncbi.nlm.nih.gov/pubmed/24709277
https://reatapharma.com/programs/ctd-pah/,https://www.ncbi.nlm.nih.gov/pubmed/26669915
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/23983198
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/16496078
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/22281797
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/19282344
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/26291092
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/20507945
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/23859338
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/23859346
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/9577387
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/20156111
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/21550666
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/10319894
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/10500204
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/23350650
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/23574943
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/19158945
https://reatapharma.com/programs/friedreichs-ataxia/,http://www.ncbi.nlm.nih.gov/pubmed/23951401
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/,http://reatapharma.wpengine.com/
https://reatapharma.com/about-us/board-of-directors/,http://reatapharma.wpengine.com/
https://reatapharma.com/our-science/rta-901/,http://reatapharma.wpengine.com/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/patients/,http://www.proxydocs.com/RETA
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/investors-news/events-presentations/,https://clinicaltrials.gov/ct2/show/NCT02036970
https://reatapharma.com/investors-news/events-presentations/,https://clinicaltrials.gov/ct2/show/NCT02657356
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/sitemap/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/legal-message/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/patients/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/careers/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/contact-us/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/sitemap/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/legal-message/
https://reatapharma.com/our-science/in-licensing/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/our-science/in-licensing/,https://twitter.com/reatapharma
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/21457778
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/19720606
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/23741300
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/25926128
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/18065492
https://reatapharma.com/programs/ctd-pah/,http://www.ncbi.nlm.nih.gov/pubmed/17363558
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/friedreichs-ataxia/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/friedreichs-ataxia/,https://twitter.com/reatapharma
https://reatapharma.com/programs/friedreichs-ataxia/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/friedreichs-ataxia/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/programs/friedreichs-ataxia/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/programs/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/kidney-diseases/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/careers/
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/patients/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/patients/,https://reatapharma.com/careers/
https://reatapharma.com/patients/,https://reatapharma.com/contact-us/
https://reatapharma.com/patients/,https://reatapharma.com/
https://reatapharma.com/patients/,https://cardinalclinicaltrial.com/
https://reatapharma.com/patients/,https://www.phoenixclinicaltrial.com/
https://reatapharma.com/patients/,https://www.moxiestudy.com/
https://reatapharma.com/patients/,https://www.catalysttrial.com/
https://reatapharma.com/patients/,https://reatapharma.com/patients/compassionate-use-policy/
https://reatapharma.com/investors-news/events-presentations/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/investors-news/events-presentations/,https://twitter.com/reatapharma
https://reatapharma.com/investors-news/events-presentations/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/investors-news/events-presentations/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/investors-news/events-presentations/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/our-science/in-licensing/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/our-science/in-licensing/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/our-science/in-licensing/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/about-us/leadership/,http://reatapharma.wpengine.com/
https://reatapharma.com/programs/ctd-pah/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/ctd-pah/,https://twitter.com/reatapharma
https://reatapharma.com/programs/ctd-pah/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/ctd-pah/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/programs/overview/,http://reatapharma.wpengine.com/
https://reatapharma.com/our-science/nrf2-activators/,http://reatapharma.wpengine.com/
https://reatapharma.com/thank-you-for-your-interest/,http://reatapharma.wpengine.com/
https://reatapharma.com/programs/,https://reatapharma.com/programs/
https://reatapharma.com/programs/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/,https://reatapharma.com/patients/
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/
https://reatapharma.com/programs/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/programs/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/patients/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/programs/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/patients/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/contact-us/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/
https://reatapharma.com/programs/kidney-diseases/,http://alportsyndrome.org/what-is-alport-syndrome/
https://reatapharma.com/programs/kidney-diseases/,http://investors.reatapharma.com/phoenix.zhtml?ID=2342167&c=254306&p=irol-newsArticle
https://reatapharma.com/programs/kidney-diseases/,http://ow.ly/K7Jq30l4Pyv
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/23720336
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/24195589
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/28978980
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600401/
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/25047252
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/26612656
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/11386927
https://reatapharma.com/patients/,https://reatapharma.wpengine.com/patients/compassionate-use-policy/
https://reatapharma.com/patients/,https://reatapharma.com/sitemap/
https://reatapharma.com/patients/,https://reatapharma.com/legal-message/
https://reatapharma.com/patients/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/patients/,https://twitter.com/reatapharma
https://reatapharma.com/patients/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/patients/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/patients/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/our-science/rta-1701/,http://www.proxydocs.com/RETA
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/careers/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/contact-us/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/
https://reatapharma.com/our-science/rta-1701/,https://www.ncbi.nlm.nih.gov/pubmed/19076351
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/ctd-pah/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/overview/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/overview/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/overview/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/programs/overview/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/overview/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/overview/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/overview/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/programs/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/,https://reatapharma.com/careers/
https://reatapharma.com/programs/,https://reatapharma.com/contact-us/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/about-us/board-of-directors/,http://www.proxydocs.com/RETA
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/careers/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/contact-us/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/our-science/rta-901/,http://www.proxydocs.com/RETA
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/our-science/rta-901/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/24206459
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/24903467
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/25307295
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/21508635
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/21699484
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/25441438
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/25441437
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/20956520
https://reatapharma.com/programs/immuno-oncology/,http://reatapharma.wpengine.com/
https://reatapharma.com/our-science/rta-1701/,https://www.ncbi.nlm.nih.gov/pubmed/26388774
https://reatapharma.com/our-science/rta-1701/,http://www.autoimmuneregistry.org/autoimmune-statistics/
https://reatapharma.com/our-science/rta-1701/,https://www.ncbi.nlm.nih.gov/pubmed/21081189
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,http://reatapharma.wpengine.com/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/programs/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/overview/,https://reatapharma.com/programs/
https://reatapharma.com/programs/overview/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/overview/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/overview/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/overview/,https://reatapharma.com/patients/
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/
https://reatapharma.com/programs/overview/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/overview/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/programs/overview/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/programs/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/patients/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/our-science/nrf2-activators/,http://www.proxydocs.com/RETA
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.com/programs/
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.com/patients/
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.gcs-web.com/
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/,https://reatapharma.com/
https://reatapharma.com/programs/,https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/
https://reatapharma.com/programs/,https://reatapharma.com/programs/iga-nephropathybard/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/sitemap/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/legal-message/
https://reatapharma.com/about-us/board-of-directors/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/about-us/board-of-directors/,https://twitter.com/reatapharma
https://reatapharma.com/about-us/board-of-directors/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/about-us/board-of-directors/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/about-us/board-of-directors/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/iga-nephropathybard/,http://reatapharma.wpengine.com/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/careers/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/contact-us/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/
https://reatapharma.com/our-science/rta-901/,http://www.ncbi.nlm.nih.gov/pubmed/20955164
https://reatapharma.com/our-science/rta-901/,http://www.ncbi.nlm.nih.gov/pubmed/17656567
https://reatapharma.com/our-science/rta-901/,http://www.ncbi.nlm.nih.gov/pubmed/10605935
https://reatapharma.com/our-science/rta-901/,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049350/
https://reatapharma.com/our-science/rta-901/,http://www.ncbi.nlm.nih.gov/pubmed/24263156
https://reatapharma.com/our-science/rta-901/,https://kuscholarworks.ku.edu/handle/1808/10216
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,http://reatapharma.wpengine.com/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,http://reatapharma.wpengine.com/
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/19698707
https://reatapharma.com/posts/,http://reatapharma.wpengine.com/
https://reatapharma.com/patients/compassionate-use-policy/,http://reatapharma.wpengine.com/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/our-science/rta-1701/,http://www.jimmunol.org/content/200/1_Supplement/121.14
https://reatapharma.com/our-science/rta-1701/,http://www.jimmunol.org/content/200/1_Supplement/175.22
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/sitemap/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/legal-message/
https://reatapharma.com/our-science/rta-1701/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/our-science/rta-1701/,https://twitter.com/reatapharma
https://reatapharma.com/our-science/rta-1701/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/our-science/rta-1701/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/our-science/rta-1701/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/programs/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/patients/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/patients/
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/overview/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/overview/,https://reatapharma.com/careers/
https://reatapharma.com/programs/overview/,https://reatapharma.com/contact-us/
https://reatapharma.com/programs/overview/,https://reatapharma.com/
https://reatapharma.com/programs/overview/,https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/
https://reatapharma.com/programs/overview/,https://reatapharma.com/programs/iga-nephropathybard/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/careers/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/contact-us/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179323/
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/23311665
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/22966038
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/20463397
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/23951401
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/thank-you-for-your-interest/,http://www.proxydocs.com/RETA
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/,https://reatapharma.com/programs/type-1-diabetic-ckdbard/
https://reatapharma.com/programs/,https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/
https://reatapharma.com/programs/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/,https://twitter.com/reatapharma
https://reatapharma.com/programs/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/programs/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/programs/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/patients/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/programs/iga-nephropathybard/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/our-science/rta-901/,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517131/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/sitemap/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/legal-message/
https://reatapharma.com/our-science/rta-901/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/our-science/rta-901/,https://twitter.com/reatapharma
https://reatapharma.com/our-science/rta-901/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/our-science/rta-901/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/our-science/rta-901/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/programs/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/26618193
https://reatapharma.com/programs/kidney-diseases/,https://academic.oup.com/ndt/article/27/suppl_2/ii11/1935265
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/16954345
https://reatapharma.com/programs/kidney-diseases/,https://www.asn-online.org/education/kidneyweek/archives/
https://reatapharma.com/programs/kidney-diseases/,https://www.sciencedirect.com/science/article/pii/0026049573902692
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/16489057
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/19371629
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/18417483
https://reatapharma.com/programs/kidney-diseases/,https://doi.org/10.1093/ndt/gfw160.01
https://reatapharma.com/programs/kidney-diseases/,https://www.ncbi.nlm.nih.gov/pubmed/10752524
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/sitemap/
https://reatapharma.com/posts/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/posts/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/posts/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/posts/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/posts/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/posts/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/posts/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/posts/,https://reatapharma.com/programs/
https://reatapharma.com/posts/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/posts/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/posts/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/posts/,https://reatapharma.com/patients/
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/
https://reatapharma.com/posts/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/programs/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/patients/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/investors-news/news-room/,http://reatapharma.wpengine.com/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/programs/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/patients/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/overview/,https://reatapharma.com/programs/type-1-diabetic-ckdbard/
https://reatapharma.com/programs/overview/,https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/
https://reatapharma.com/programs/overview/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/overview/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/overview/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/overview/,https://twitter.com/reatapharma
https://reatapharma.com/programs/overview/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/overview/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/programs/overview/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/23716596
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613643/
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/23896025
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/10638762
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/10617085
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/19189297
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/18413762
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/17148759
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pubmed/16968214
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003357/
https://reatapharma.com/our-science/nrf2-activators/,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752754/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/sitemap/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/legal-message/
https://reatapharma.com/our-science/nrf2-activators/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/our-science/nrf2-activators/,https://twitter.com/reatapharma
https://reatapharma.com/our-science/nrf2-activators/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.com/careers/
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.com/contact-us/
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.com/
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.com/sitemap/
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.com/legal-message/
https://reatapharma.com/thank-you-for-your-interest/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/thank-you-for-your-interest/,https://twitter.com/reatapharma
https://reatapharma.com/thank-you-for-your-interest/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/thank-you-for-your-interest/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/thank-you-for-your-interest/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/careers/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/contact-us/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/patients/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/programs/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/patients/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/kidney-diseases/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/kidney-diseases/,https://twitter.com/reatapharma
https://reatapharma.com/programs/kidney-diseases/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/kidney-diseases/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/programs/kidney-diseases/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/posts/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/posts/,http://www.proxydocs.com/RETA
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/posts/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/posts/,https://reatapharma.com/careers/
https://reatapharma.com/posts/,https://reatapharma.com/contact-us/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/patients/compassionate-use-policy/,http://www.proxydocs.com/RETA
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/programs/immuno-oncology/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/careers/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/contact-us/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,http://alportsyndrome.org/what-is-alport-syndrome/
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/about-us/leadership/,http://www.proxydocs.com/RETA
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/about-us/leadership/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/careers/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/contact-us/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/sitemap/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/legal-message/
https://reatapharma.com/about-us/leadership/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/our-science/nrf2-activators/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/our-science/nrf2-activators/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/iga-nephropathybard/,http://alportsyndrome.org/what-is-alport-syndrome/
https://reatapharma.com/programs/iga-nephropathybard/,http://investors.reatapharma.com/phoenix.zhtml?ID=2342167&c=254306&p=irol-newsArticle
https://reatapharma.com/programs/iga-nephropathybard/,http://ow.ly/K7Jq30l4Pyv
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/23720336
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/24195589
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/28978980
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,http://www.proxydocs.com/RETA
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/nephrology-kol/,http://reatapharma.wpengine.com/
https://reatapharma.com/share-your-fa-story/writing-tips/,https://reatapharma.com/share-your-fa-story/
https://reatapharma.com/share-your-fa-story/thank-you/,https://reatapharma.com/share-your-fa-story/
https://reatapharma.com/share-your-fa-story/thank-you/,https://reatapharma.com/share-your-fa-story/writing-tips/
https://reatapharma.com/share-your-fa-story/thank-you/,https://reatapharma.com/share-your-fa-story/submission-guidelines/
https://reatapharma.com/share-your-fa-story/thank-you/,https://reatapharma.com/share-your-fa-story/terms-and-conditions/
https://reatapharma.com/share-your-fa-story/thank-you/,https://reatapharma.com/privacy-policy
https://reatapharma.com/share-your-fa-story/thank-you/,https://reatapharma.com/
https://reatapharma.com/share-your-fa-story/terms-and-conditions/,https://reatapharma.com/share-your-fa-story/
https://reatapharma.com/share-your-fa-story/terms-and-conditions/,https://reatapharma.com/share-your-fa-story/writing-tips/
https://reatapharma.com/share-your-fa-story/terms-and-conditions/,https://reatapharma.com/share-your-fa-story/submission-guidelines/
https://reatapharma.com/share-your-fa-story/submission-guidelines/,https://reatapharma.com/share-your-fa-story/
https://reatapharma.com/share-your-fa-story/submission-guidelines/,https://reatapharma.com/share-your-fa-story/writing-tips/
https://reatapharma.com/share-your-fa-story/submission-guidelines/,https://reatapharma.com/share-your-fa-story/submission-guidelines/
https://reatapharma.com/share-your-fa-story/submission-guidelines/,https://reatapharma.com/share-your-fa-story/terms-and-conditions/
https://reatapharma.com/share-your-fa-story/submission-guidelines/,https://reatapharma.com/privacy-policy
https://reatapharma.com/share-your-fa-story/submission-guidelines/,https://reatapharma.com/
https://reatapharma.com/share-your-fa-story/,https://reatapharma.com/share-your-fa-story/
https://reatapharma.com/posts/,https://reatapharma.com/
https://reatapharma.com/posts/,http://ow.ly/xiSb30l32TC
https://reatapharma.com/posts/,https://reatapharma.com/programs
https://reatapharma.com/posts/,https://reatapharma.com/sitemap/
https://reatapharma.com/posts/,https://reatapharma.com/legal-message/
https://reatapharma.com/posts/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/posts/,https://twitter.com/reatapharma
https://reatapharma.com/posts/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/careers/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/contact-us/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/
https://reatapharma.com/patients/compassionate-use-policy/,https://clinicaltrials.gov/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/sitemap/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/legal-message/
https://reatapharma.com/patients/compassionate-use-policy/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/patients/compassionate-use-policy/,https://twitter.com/reatapharma
https://reatapharma.com/patients/compassionate-use-policy/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/patients/compassionate-use-policy/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/patients/compassionate-use-policy/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/programs/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/patients/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/investors-news/news-room/,http://www.proxydocs.com/RETA
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/careers/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/contact-us/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/
https://reatapharma.com/programs/immuno-oncology/,https://clinicaltrials.gov/ct2/show/NCT02259231
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/product-pipeline/immuno-oncology/melanoma/
https://reatapharma.com/programs/immuno-oncology/,http://www.ncbi.nlm.nih.gov/pubmed/26091825
https://reatapharma.com/programs/immuno-oncology/,http://www.ncbi.nlm.nih.gov/pubmed/19380816
https://reatapharma.com/programs/immuno-oncology/,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2840181/
https://reatapharma.com/programs/immuno-oncology/,http://www.ncbi.nlm.nih.gov/pubmed/21911941
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,http://investors.reatapharma.com/phoenix.zhtml?ID=2342167&c=254306&p=irol-newsArticle
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,http://ow.ly/K7Jq30l4Pyv
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/23720336
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/24195589
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/28978980
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600401/
https://reatapharma.com/about-us/leadership/,https://twitter.com/reatapharma
https://reatapharma.com/about-us/leadership/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/about-us/leadership/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/about-us/leadership/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600401/
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/25047252
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/26612656
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/11386927
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/24206459
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/24903467
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/25307295
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/21508635
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/21699484
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/25441438
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/25441437
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/20956520
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/19698707
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/26618193
https://reatapharma.com/programs/iga-nephropathybard/,https://academic.oup.com/ndt/article/27/suppl_2/ii11/1935265
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/16954345
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/careers/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/contact-us/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,http://alportsyndrome.org/what-is-alport-syndrome/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,http://investors.reatapharma.com/phoenix.zhtml?ID=2342167&c=254306&p=irol-newsArticle
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,http://ow.ly/K7Jq30l4Pyv
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/23720336
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/24195589
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/careers/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/contact-us/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/about-us/our-story/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/about-us/leadership/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/about-us/board-of-directors/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/our-science/nrf2-activators/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/our-science/rta-901/
https://reatapharma.com/share-your-fa-story/writing-tips/,https://reatapharma.com/share-your-fa-story/writing-tips/
https://reatapharma.com/share-your-fa-story/writing-tips/,https://reatapharma.com/share-your-fa-story/submission-guidelines/
https://reatapharma.com/share-your-fa-story/writing-tips/,https://reatapharma.com/share-your-fa-story/terms-and-conditions/
https://reatapharma.com/share-your-fa-story/writing-tips/,https://reatapharma.com/privacy-policy
https://reatapharma.com/share-your-fa-story/writing-tips/,https://reatapharma.com/
https://reatapharma.com/share-your-fa-story/terms-and-conditions/,https://reatapharma.com/privacy-policy
https://reatapharma.com/share-your-fa-story/terms-and-conditions/,http://www.fda.gov/medwatch
https://reatapharma.com/share-your-fa-story/terms-and-conditions/,https://reatapharma.com/share-your-fa-story/terms-and-conditions/
https://reatapharma.com/share-your-fa-story/terms-and-conditions/,https://reatapharma.com/
https://reatapharma.com/share-your-fa-story/,https://reatapharma.com/share-your-fa-story/writing-tips/
https://reatapharma.com/share-your-fa-story/,https://reatapharma.com/share-your-fa-story/submission-guidelines/
https://reatapharma.com/share-your-fa-story/,https://reatapharma.com/privacy-policy
https://reatapharma.com/share-your-fa-story/,http://www.fda.gov/medwatch
https://reatapharma.com/share-your-fa-story/,https://reatapharma.com/share-your-fa-story/terms-and-conditions
https://reatapharma.com/share-your-fa-story/,https://reatapharma.com/share-your-fa-story/submission-guidelines
https://reatapharma.com/share-your-fa-story/,https://reatapharma.com/share-your-fa-story/terms-and-conditions/
https://reatapharma.com/posts/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/posts/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/investors-news/news-room/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/careers/
https://reatapharma.com/programs/immuno-oncology/,http://www.ncbi.nlm.nih.gov/pubmed/21784871
https://reatapharma.com/programs/immuno-oncology/,http://www.ncbi.nlm.nih.gov/pubmed/16557582
https://reatapharma.com/programs/immuno-oncology/,http://www.ncbi.nlm.nih.gov/pubmed/22966038
https://reatapharma.com/programs/immuno-oncology/,http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405374/
https://reatapharma.com/programs/immuno-oncology/,http://www.ncbi.nlm.nih.gov/pubmed/22437870
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/immuno-oncology/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/25047252
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/26612656
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/11386927
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/24206459
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/24903467
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/25307295
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/21508635
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/21699484
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/25441438
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/25441437
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/20956520
https://reatapharma.com/programs/iga-nephropathybard/,https://www.asn-online.org/education/kidneyweek/archives/
https://reatapharma.com/programs/iga-nephropathybard/,https://www.sciencedirect.com/science/article/pii/0026049573902692
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/16489057
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/19371629
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/18417483
https://reatapharma.com/programs/iga-nephropathybard/,https://doi.org/10.1093/ndt/gfw160.01
https://reatapharma.com/programs/iga-nephropathybard/,https://www.ncbi.nlm.nih.gov/pubmed/10752524
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/iga-nephropathybard/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/iga-nephropathybard/,https://twitter.com/reatapharma
https://reatapharma.com/programs/iga-nephropathybard/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/iga-nephropathybard/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/programs/iga-nephropathybard/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/28978980
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600401/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/25047252
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/26612656
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/11386927
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/24206459
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/24903467
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/25307295
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/21508635
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/21699484
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/25441438
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/25441437
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/20956520
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,http://alportsyndrome.org/what-is-alport-syndrome/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,http://investors.reatapharma.com/phoenix.zhtml?ID=2342167&c=254306&p=irol-newsArticle
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,http://ow.ly/K7Jq30l4Pyv
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/23720336
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/24195589
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/28978980
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600401/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/25047252
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/26612656
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/11386927
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/24206459
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/24903467
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/25307295
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/21508635
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/our-science/rta-1701/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/our-science/in-licensing/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/programs/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/programs/kidney-diseases/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/programs/friedreichs-ataxia/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/programs/ctd-pah/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/patients/
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/investors-news/events-presentations/
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/events-and-presentations/upcoming-events
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/news-releases
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/investors-news/social-media-disclosure/
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/financial-information/sec-filings
https://reatapharma.com/nephrology-kol/,http://www.proxydocs.com/RETA
https://reatapharma.com/share-your-fa-story/,https://reatapharma.com/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/contact-us/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/sitemap/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/legal-message/
https://reatapharma.com/investors-news/news-room/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/investors-news/news-room/,https://twitter.com/reatapharma
https://reatapharma.com/investors-news/news-room/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/investors-news/news-room/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/investors-news/news-room/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/immuno-oncology/,https://twitter.com/reatapharma
https://reatapharma.com/programs/immuno-oncology/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/immuno-oncology/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/programs/immuno-oncology/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/19698707
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/26618193
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://academic.oup.com/ndt/article/27/suppl_2/ii11/1935265
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/16954345
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.asn-online.org/education/kidneyweek/archives/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.sciencedirect.com/science/article/pii/0026049573902692
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/16489057
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/19371629
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/18417483
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://doi.org/10.1093/ndt/gfw160.01
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.ncbi.nlm.nih.gov/pubmed/10752524
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/19698707
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/26618193
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://academic.oup.com/ndt/article/27/suppl_2/ii11/1935265
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/16954345
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.asn-online.org/education/kidneyweek/archives/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.sciencedirect.com/science/article/pii/0026049573902692
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/16489057
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/19371629
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/21699484
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/25441438
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/25441437
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/20956520
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/19698707
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/financial-information/quarterly-results
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/corporate-governance
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/corporate-governance/committee-composition
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/corporate-governance/contact-the-board
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/shareholder-services/document-request
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/shareholder-services/email-alerts
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://twitter.com/reatapharma
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/programs/type-1-diabetic-ckdbard/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/18417483
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://doi.org/10.1093/ndt/gfw160.01
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.ncbi.nlm.nih.gov/pubmed/10752524
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://twitter.com/reatapharma
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/programs/autosomal-dominant-polycystic-kidney-diseasebard/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/26618193
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://academic.oup.com/ndt/article/27/suppl_2/ii11/1935265
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/16954345
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.asn-online.org/education/kidneyweek/archives/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.sciencedirect.com/science/article/pii/0026049573902692
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/16489057
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/19371629
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/18417483
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://doi.org/10.1093/ndt/gfw160.01
https://reatapharma.com/nephrology-kol/,https://reatapharma.gcs-web.com/shareholder-services/contact-ir
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/careers/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/contact-us/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.ncbi.nlm.nih.gov/pubmed/10752524
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/sitemap/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/legal-message/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://twitter.com/reatapharma
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/sitemap/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/legal-message/
https://reatapharma.com/nephrology-kol/,https://reatapharma.com/privacy-policy/
https://reatapharma.com/nephrology-kol/,https://twitter.com/reatapharma
https://reatapharma.com/nephrology-kol/,https://www.linkedin.com/company/reata-pharmaceuticals/
https://reatapharma.com/programs/focal-segmental-glomerulosclerosisbard/,https://www.instagram.com/reatapharmaceuticals/
https://reatapharma.com/nephrology-kol/,https://www.facebook.com/ReataPharma/
https://reatapharma.com/nephrology-kol/,https://www.instagram.com/reatapharmaceuticals/
